Latest Articles

Publication Date
Assessing Practice Patterns Regarding Use of Norethindrone Acetate in Adolescents.

Norethindrone acetate (NETA) is commonly used in adolescent patients for management of heavy menstrual bleeding, menstrual suppression, and endometriosis. Clinical guidelines do not address specific dosing strategies, clinical indications, contraindications, …

Published: Dec. 10, 2024, midnight
The impact of persistent organic pollutants on fertility: exposure to the environmental toxicant 2,3,7,8-tetrachlorodibenzo-p-dioxin alters reproductive tract immune responses.

Exposure to environmental contaminants can result in profound effects on the host immune system. One class of environmental toxicants, known as dioxins, are persistent environmental contaminants termed "forever chemicals". The …

Published: Dec. 10, 2024, midnight
Controversial Roles of Autophagy in Adenomyosis and Its Implications for Fertility Outcomes-A Systematic Review.

Background/Objectives: Adenomyosis is a benign condition where ectopic endometrial glandular tissue is found within the uterine myometrium. Its impact on women's reproductive outcomes is substantial, primarily due to defective decidualization, …

Published: Dec. 10, 2024, midnight
Nociplastic Pain in Endometriosis: A Scoping Review.

Endometriosis is an inflammatory chronic condition associated with nociceptive, neuropathic, and nociplastic pain. Central sensitization (CS) is the primary nociplastic pain mechanism. However, there are currently no standardized methods for …

Published: Dec. 10, 2024, midnight
Adhesion Prevention in Gynecologic Surgery: Guidance and Clinical Experience.

Postoperative adhesions represent a major medical challenge and are associated with serious health and economic consequences. 4DryField® PH (PlantTec Medical GmbH, Lueneburg, Germany) is a starch-based medical device designed both …

Published: Dec. 10, 2024, midnight
Endometriosis Treatment Market Projected to Reach $3.1 Billion by 2034: Advancements in Surgery and Fertility Therapies Fuel Growth - PharmiWeb.com

Endometriosis Treatment Market Projected to Reach $3.1 Billion by 2034: Advancements in Surgery and Fertility Therapies Fuel Growth PharmiWeb.com

Published: Dec. 9, 2024, 10 p.m.
Doctors call for enhanced awareness campaigns on endometriosis - The Star Kenya

Doctors call for enhanced awareness campaigns on endometriosis The Star Kenya

Published: Dec. 9, 2024, 4 p.m.
Planned Home Births Are Safe for Low-Risk Pregnancies - Endocrinology Advisor

Planned Home Births Are Safe for Low-Risk Pregnancies Endocrinology Advisor

Published: Dec. 9, 2024, 2:40 p.m.
Endometriosis drug research, long underfunded, confronts familiar problems in women’s health - BioPharma Dive

Endometriosis drug research, long underfunded, confronts familiar problems in women’s health BioPharma Dive

Published: Dec. 9, 2024, 1:02 p.m.
Cost-effectiveness of long-acting progestogens versus the combined oral contraceptives pill for preventing recurrence of endometriosis-related pain following surgery: an economic evaluation alongside the PRE-EMPT trial.

To evaluate the cost-effectiveness of long-acting progestogens (LAP), including levonorgestrel-releasing intrauterine system (LNG-IUS) and depot-medroxyprogesterone acetate (DMPA), compared with the combined oral contraceptives pill (COCP) in preventing recurrence of endometriosis-related …

Published: Dec. 9, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!